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Stillbirths: the hidden burden of malaria in pregnancy
Globally, most stillbirths are preventable.1 An estimated 
2·6 million third-trimester stillbirths occur annually, 
and over 90% of these stillbirths result from modifiable 
medical conditions. Such disorders include chronic non-
communicable diseases such as obesity, hypertension, 
and diabetes; obstetric conditions such as advanced 
maternal age and post-term pregnancies; and infections 
such as malaria and syphilis. Given the epidemiology 
of these factors, stillbirths occur at the highest rates in 
southern Asia (25·5 per 1000 births) and sub-Saharan 
Africa (28·7 per 1000 births). Despite this burden, 
stillbirth was a somewhat neglected tragedy up until 
the past 5 years in the landscape of maternal and child 
health,2 which has more commonly focused on improving 
neonatal and under-5 survival.1 With sustained progress 
towards meeting goals established for these groups, 
renewed attention has been directed towards the 
measurement and prevention of stillbirth as a component 
of the Every Newborn Action Plan (ENAP) from WHO 
and UNICEF.3 The ENAP, launched in 2014 and endorsed 
by 194 member states of the World Health Assembly, 
named as one of two explicit goals an end to preventable 
stillbirths by 2035.3 Although the strategy to achieve this 
goal is primarily a renewal of focus on improving access to 
skilled care at birth, the ENAP has deservedly established 
the prevention of stillbirth on the global health agenda.
Antenatal malaria prevention strategies vary 
throughout the tropics: in malaria-endemic Africa, 
programmes are founded on the use of insecticide-
treated bednets, intermittent preventive therapy 
with antimalarials, and effective case management, 
whereas programmes elsewhere are more varied and 
use combinations of insecticide-treated bednets with 
active or passive case detection and case management.4 
Malaria in pregnancy can have devastating 
consequences for the developing fetus, resulting in 
preterm delivery and intrauterine-growth retardation, 
and is believed to be a major contributor to spontaneous 
abortions and stillbirths. The magnitude of this effect 
on pregnancy loss has not been well documented, and 
it is also unclear how this effect might be modified by 
the intensity of malaria transmission, which determines 
the extent of acquired protective immunity among 
pregnant women and thus their risk of complications of 
antenatal malaria infections.5
In The Lancet Global Health, Kerryn Moore and 
colleagues6 confirm that antenatal malaria is a major 
cause of stillbirth. The authors did a systematic review 
and meta-analysis of 59 studies to estimate the 
contribution to stillbirths of Plasmodium falciparum 
and P vivax infections during pregnancy. Their 
analysis expands our understanding of the previously 
underestimated burden of the consequences of 
antenatal malaria, and has implications for Africa 
and other malaria-endemic regions. First, the study 
definitively and comprehensively measures the elevated 
risk of stillbirth conferred by P falciparum malaria 
during pregnancy. Across nearly 20 studies, antenatal 
infections that were detected and treated increased 
the odds of stillbirth by 1·47 times, whereas in over 
30 studies, infections at delivery in the mother increased 
the odds of stillbirth by 1·81 times and malaria in the 
placenta increased the odds of stillbirth by 1·95 times. 
By calculating population-attributable fractions, the 
authors estimate that in Africa, where stillbirth and 
P falciparum malaria coexist most commonly, between 
132 000 and 221 000 stillbirths per year might result 
from antenatal P falciparum malaria, representing 12% 
and 20% of all stillbirths in this region. P vivax malaria, 
which is endemic throughout the tropics outside of 
Africa, was associated with a 2·81 times increased odds 
for stillbirth, but this association was not significant and 
based on only three studies.
Another interesting finding reported by Moore and 
colleagues was that the risk of stillbirth conferred by 
P falciparum malaria is modified by the intensity of 
malaria transmission. Compared with studies done 
in moderately-to-highly endemic areas, the malaria-
associated increase in stillbirth in low-to-intermediate 
areas was roughly doubled. Why is this important? 
As we move towards malaria elimination, protective 
immunity will wane in populations with pre-existing 
immunity. These low levels of protective immunity 
in pregnant women result in more severe clinical 
manifestations of malaria, including higher densities 
of placental infections in settings with more sustained 
levels of transmission.7 Thus, as infection becomes 
less common because of decreasing transmission, the 
clinical severity of those infections, including the risk 
of stillbirth, might increase. Furthermore, reductions in 
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protective immunity might shift the burden of malaria 
in pregnancy more widely across all gravidae rather than 
being concentrated in first and second pregnancies. 
For these reasons, malaria is likely to remain an 
important risk factor for stillbirth in the foreseeable 
future. Therefore, even in areas where transmission has 
decreased considerably, protection of pregnant women 
from malaria will remain crucial.
In the past 15 years, programmes that protect 
susceptible populations with vector control measures, 
highly-effective treatment, and targeted prophylaxis 
have substantially reduced malaria-associated deaths 
in Africa.8 However, these new data by Moore and 
colleagues highlight a hidden burden of malaria 
mortality, because stillbirths are not captured in 
standard estimates of infant and under-5 mortality. 
These data suggest that accelerated progress in 
perinatal survival rates by reducing stillbirths can 
be achieved by investment in strategies to enhance 
the effectiveness and uptake of antenatal malaria 
prevention, which remain low in many areas.9 
Recognition of this hidden burden of malaria might 
also provide a previously hidden opportunity to reduce 
the immiserating burden of stillbirth in malaria-
endemic areas.
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